Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril versus placebo for early renal involvement in children with sickle cell disease
2009-009952-18Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sickle cell disease (SCD) and albuminuria comparing Enalapril with Placebo (2 arms). Primary endpoint: Change in albumin-to-creatinine ratio. Started Nov 2009; status: active.
02
Drugs
enalapril
03
Conditions
sickle cell disease (SCD)albuminuria
Beyond the preview
Go deeper on 2009-009952-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009952-18.